Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:743-748
Published online before print January 8, 2009, doi: 10.1161/STROKEAHA.108.526772
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/743    most recent
STROKEAHA.108.526772v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, A.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Acute Stroke Syndromes
Right arrow Emergency treatment of Stroke
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Thrombolysis

(Stroke. 2009;40:743.)
© 2009 American Heart Association, Inc.


Original Contributions

Oxfordshire Community Stroke Project Clinical Stroke Syndrome and Appearances of Tissue and Vascular Lesions on Pretreatment CT in Hyperacute Ischemic Stroke Among the First 510 Patients in the Third International Stroke Trial (IST-3)

Adam Kobayashi, MD, PhD; Joanna M. Wardlaw, MBChB, MD, FRCR, FRCP, FMedSci; Richard I. Lindley, MD, FRCP, FRACP; Steff C. Lewis, PhD, MSci; Peter A.G. Sandercock, DM, FRCPE, FMedSci; Anna Czlonkowska, MD, PhD on behalf of the IST-3 Collaborative Group

From the 2nd Department of Neurology (A.K., A.C.), Institute of Psychiatry and Neurology, Warsaw, Poland; the Department of Experimental and Clinical Pharmacology (A.K., A.C.), Medical University of Warsaw, Poland; the Division of Clinical Neurosciences (J.M.W., S.C.L., P.A.G.S.), University of Edinburgh, Western General Hospital, UK; and the Discipline of Medicine (R.I.L.), Westmead Hospital (C24), The University of Sydney, Australia.

Correspondence to Adam Kobayashi, 2nd Department of Neurology, Institute of Psychiatry and Neurology, ul. Sobieskiego 9, 02-957 Warsaw, Poland. E-mail akobayas{at}ipin.edu.pl

Background and Purpose— The Oxfordshire Community Stroke Project (OCSP) clinical stroke syndrome classification correlates well with the stroke lesion in established ischemic stroke, but there are few data in patients with hyperacute stroke. We wished to assess whether the OCSP correlated with the site and size of the ischemic lesion and location of cerebral vessel lesion on computed tomography (CT) in hyperacute stroke.

Methods— Prospective study of ischemic stroke patients presenting within 6 hours of onset in the Third International Stroke Trial (IST-3), a randomized, controlled trial of rt-PA. OCSP syndrome was assigned by a computer-based algorithm. The CT assessment was made by a neuroradiologist blinded to clinical details.

Results— We assessed baseline data and CT findings for the first 510 patients; early tissue ischemic changes were present in 329/510 (65%) total anterior circulation syndrome (TACS) - 79%; partial anterior circulation syndrome (PACS) - 57%, lacunar syndrome (LACS) - 40%; posterior circulation syndrome (POCS) - 33%. The site and size of ischemic change on CT was compatible with the clinical syndrome in 79%, 37%, 2%, and 14%, respectively. Assuming that all patients with a normal CT scan will develop an incompatible lesion these numbers reflected the "worst possible scenario." For the "best possible scenario" we presumed that those with a normal CT will develop concordant ischemic change and the proportions were 100%, 80%, 62% and 81%, respectively. The hyperattenuated artery sign was seen in 206/510 (40%); (TACS 54%; PACS 35%, LACS 5%, and POCS 19%).

Conclusions— Within 6 hours of stroke, in patients with a nonlacunar syndrome, the OCSP syndrome correlated well with the pattern of ischemic change on CT. For clinicians who wish to restrict the use of thrombolytic therapy to large-artery ischemic stroke, concordance of clinical and CT appearances may give greater confidence in making therapeutic decisions in hyperacute stroke. In centers where immediate access to MR is limited, use of the classification may help focus use of MR on patients with suspected LACS and POCS. The utility of the classification may further increase if IST-3 establishes that the OCSP syndrome significantly modifies response to thrombolytic therapy.


Key Words: acute stroke • OCSP classification • computed tomography • ischemic change • hyperattenuated artery sign